1847 Holdings Acquires ICU Eyewear Holdings Inc.

Inspecs Group plc Acquires Eschenbach Holding GmbH from Equistone

November 19, 2020

Consumer Products

British eyewear designer and manufacturer Inspecs Group plc has agreed to acquire a majority stake in Nuremberg-based Eschenbach Holding GmbH from funds advised by Equistone Partners Europe. The deal (reported at approximately €94.85 million) combines two leading eyewear businesses to strengthen the enlarged group's global market position, broaden product and customer portfolios and accelerate international expansion; the transaction remains subject to regulatory approvals.

Unifeye Vision Partners Acquires Insight Vision Group

September 18, 2023

Healthcare Services

Unifeye Vision Partners, a portfolio company of Waud Capital, has acquired Insight Vision Group, a California-based ophthalmology platform that combines DLV Vision and ADV Vision. The deal adds 10 clinics and 2 ambulatory surgery centers to Unifeye's network and expands the buyer's West Coast footprint; financial terms were not disclosed.

Beverly Capital Acquires The Eye Health Group

February 12, 2021

Healthcare Services

Los Angeles-based private equity firm Beverly Capital has acquired The Eye Health Group, a New Jersey-based optometric service provider. Everside Capital Partners and Merion Investment Partners provided subordinated debt and equity support for the transaction; the seller will remain invested and management will continue to operate the business as the investors pursue a roll-up strategy across the Northeast.

New Look Vision Group Acquires Luxury Optical Holdings

December 1, 2021

Healthcare Services

New Look Vision Group entered into a definitive agreement to acquire Luxury Optical Holdings (LOH), a New York–based luxury optical retailer with 34 locations. The deal expands New Look Vision Group’s U.S. footprint and continues growth in both retail/wholesale and product development, with LOH planned to operate as a separate stand-alone business unit under Tim Mayhew.

Oakley Capital Origin Fund I Acquires Majority Stake in Horizons Optical

March 18, 2024

Medical Devices

Oakley Capital Origin Fund I is acquiring a majority stake in Horizons Optical from Sherpa Capital, with CEO Santiago Soler retaining a significant share and remaining CEO. Horizons, founded in Barcelona in 2017, provides proprietary medical software and scanning equipment used by independent laboratories and opticians to manufacture premium bespoke spectacle lenses; Oakley will support international expansion and R&D, and invest in Sales & Marketing to accelerate growth.

Santen Acquires Eyevance Pharmaceuticals for $225M

September 16, 2020

Pharmaceuticals

Santen Pharmaceutical Co., Ltd., through its U.S. subsidiary Santen Holdings U.S. Inc., acquired all outstanding shares of Eyevance Pharmaceuticals Holdings Inc. for $225 million in cash. The deal brings Eyevance’s topical ophthalmic product portfolio and U.S. commercial team into Santen’s global ophthalmology business; two development-stage assets (VISOVANQ and NEXAGON) were carved out and excluded from the purchase.